CY1123596T1 - Θεραπεια της κοκκιδιωσης με ενδομυϊκες συνθεσεις τριαζινης - Google Patents

Θεραπεια της κοκκιδιωσης με ενδομυϊκες συνθεσεις τριαζινης

Info

Publication number
CY1123596T1
CY1123596T1 CY20201100985T CY201100985T CY1123596T1 CY 1123596 T1 CY1123596 T1 CY 1123596T1 CY 20201100985 T CY20201100985 T CY 20201100985T CY 201100985 T CY201100985 T CY 201100985T CY 1123596 T1 CY1123596 T1 CY 1123596T1
Authority
CY
Cyprus
Prior art keywords
coccidiosis
treatment
compositions
intramuscular
triazine compositions
Prior art date
Application number
CY20201100985T
Other languages
English (en)
Inventor
Hamadi Karembe
Roman Krejci
Jérôme GUYONNET
Hannelie Cilliers
Original Assignee
Ceva Santé Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47351541&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1123596(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ceva Santé Animale filed Critical Ceva Santé Animale
Publication of CY1123596T1 publication Critical patent/CY1123596T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σε συνθέσεις και μεθόδους για θεραπεία της κοκκιδίωσης σε μη-ανθρώπινα θηλαστικά. Πιο ιδιαιτέρως, η εφεύρεση αφορά σε ενδομυϊκές συνθέσεις και μεθόδους για θεραπεία κοκκιδίωσης με τριαζίνη.
CY20201100985T 2012-12-07 2020-10-19 Θεραπεια της κοκκιδιωσης με ενδομυϊκες συνθεσεις τριαζινης CY1123596T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12306547.6A EP2740470A1 (en) 2012-12-07 2012-12-07 Treatment of Coccidiosis with intramuscular triazine composition
EP13815401.8A EP2928455B1 (en) 2012-12-07 2013-12-06 Treatment of coccidiosis with intramuscular triazine compositions
PCT/EP2013/075757 WO2014086959A1 (en) 2012-12-07 2013-12-06 Treatment of coccidiosis with intramuscular triazine compositions

Publications (1)

Publication Number Publication Date
CY1123596T1 true CY1123596T1 (el) 2022-03-24

Family

ID=47351541

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20201100985T CY1123596T1 (el) 2012-12-07 2020-10-19 Θεραπεια της κοκκιδιωσης με ενδομυϊκες συνθεσεις τριαζινης

Country Status (22)

Country Link
US (1) US20150320756A1 (el)
EP (4) EP2740470A1 (el)
JP (1) JP2016501253A (el)
KR (1) KR102242354B1 (el)
CN (3) CN112426426A (el)
AU (1) AU2013353983A1 (el)
BR (1) BR112015013178A2 (el)
CA (2) CA3177623A1 (el)
CL (1) CL2015001564A1 (el)
CY (1) CY1123596T1 (el)
DK (2) DK2928455T3 (el)
ES (2) ES2816525T3 (el)
HR (1) HRP20201703T1 (el)
HU (1) HUE051190T2 (el)
MX (2) MX2015007129A (el)
PH (1) PH12015501283A1 (el)
PL (2) PL3566695T3 (el)
PT (1) PT3566695T (el)
RU (2) RU2717821C2 (el)
SI (1) SI3566695T1 (el)
UA (1) UA115344C2 (el)
WO (1) WO2014086959A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP3578182A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulations containing triazinones and iron with a low amount of free iron ions
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
KR102259950B1 (ko) * 2021-02-17 2021-06-02 경상국립대학교산학협력단 복합 이온미네랄 용액을 유효성분으로 함유하는 콕시듐증의 예방 또는 개선용 조성물

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1183940A (en) 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
US3970752A (en) * 1973-03-20 1976-07-20 Bayer Aktiengesellschaft Coccidiocidal compositions utilizing 1-phenyl-substituted 1,3,5-triazine
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4493826A (en) * 1982-01-25 1985-01-15 Schering Corporation Gentamicin-gleptoferron compositions
US5219853A (en) 1983-01-12 1993-06-15 Bayer Aktiengesellschaft Agent for coccidiosis
DE3300793A1 (de) 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
DE3516632A1 (de) 1985-05-09 1986-11-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,3,5-triazintrionen
JPH0776524A (ja) * 1993-07-13 1995-03-20 Takeda Chem Ind Ltd 動物用抗貧血剤
DE19603954C2 (de) 1996-02-05 2003-04-17 Wagon Automotive Gmbh Prallträger für ein Kraftfahrzeug
DE19603984A1 (de) 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
US6470017B1 (en) 1998-04-21 2002-10-22 Nippon Telegraph And Telephone Corporation Packet multiplexing apparatus
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
CN1189175C (zh) * 1998-10-08 2005-02-16 高新研究公司 用于预防和治疗原虫病的组合物和方法
AU4034800A (en) 1999-10-08 2001-04-23 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE102004042958A1 (de) * 2004-09-02 2006-03-09 Bayer Healthcare Ag Neue antiparasitäre Kombination von Wirkstoffen
WO2006058426A1 (en) 2004-12-01 2006-06-08 Wlt Distributors Inc. Needle-free injector
ES2785210T3 (es) 2006-06-07 2020-10-06 Acushot Inc Mecanismo de carga para un inyector sin aguja
DE102006038292A1 (de) 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
CN102112167A (zh) 2008-03-07 2011-06-29 医用注射器公司 皮内注射器及其用途
SI22751A (sl) 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
US20100257667A1 (en) 2009-04-10 2010-10-14 James Kennedy Ventilated Toilet
FR2946882B1 (fr) * 2009-06-18 2011-08-26 Ceva Sante Animale Suspension veterinaire gelifiee de fer
DE102009038949A1 (de) * 2009-08-26 2011-03-03 Bayer Animal Health Gmbh Neue Verwendung von heterocyclisch substituierten 1,2,4-Triazindionen
CN101947201B (zh) 2010-09-08 2011-12-28 洛阳惠中兽药有限公司 兽药纳米混悬剂及其制备方法与应用
CN102512366A (zh) 2011-12-28 2012-06-27 广州市和生堂动物药业有限公司 妥曲珠利悬浮乳剂及其制备方法
CN102743334A (zh) * 2012-07-30 2012-10-24 郑州后羿制药有限公司 一种妥曲珠利注射剂及其制备方法
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740469A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies

Also Published As

Publication number Publication date
CA3177623A1 (en) 2014-06-12
CA2892887C (en) 2023-08-08
RU2717821C2 (ru) 2020-03-26
RU2015127023A (ru) 2017-01-10
EP3747429A1 (en) 2020-12-09
BR112015013178A2 (pt) 2017-07-11
PL2928455T3 (pl) 2020-02-28
DK2928455T3 (da) 2019-11-25
US20150320756A1 (en) 2015-11-12
PL3566695T3 (pl) 2021-04-06
EP3566695A1 (en) 2019-11-13
PH12015501283B1 (en) 2015-08-24
CL2015001564A1 (es) 2015-10-23
KR102242354B1 (ko) 2021-04-21
EP2928455B1 (en) 2019-08-21
KR20150105326A (ko) 2015-09-16
EP2928455A1 (en) 2015-10-14
WO2014086959A1 (en) 2014-06-12
MX2021006166A (es) 2021-06-30
MX2015007129A (es) 2015-10-20
UA115344C2 (uk) 2017-10-25
AU2013353983A1 (en) 2015-06-11
EP3566695B1 (en) 2020-08-05
PT3566695T (pt) 2020-10-23
SI3566695T1 (sl) 2020-12-31
EP2740470A1 (en) 2014-06-11
HUE051190T2 (hu) 2021-03-01
DK3566695T3 (en) 2020-08-24
JP2016501253A (ja) 2016-01-18
HRP20201703T1 (hr) 2020-12-25
ES2816525T3 (es) 2021-04-05
CN111714450A (zh) 2020-09-29
ES2761574T3 (es) 2020-05-20
CN112426426A (zh) 2021-03-02
CA2892887A1 (en) 2014-06-12
RU2020111176A (ru) 2021-09-20
PH12015501283A1 (en) 2015-08-24
CN104994840A (zh) 2015-10-21

Similar Documents

Publication Publication Date Title
CY1123596T1 (el) Θεραπεια της κοκκιδιωσης με ενδομυϊκες συνθεσεις τριαζινης
CY1120556T1 (el) Δικυκλικα ετεροκυκλα ως αναστολεις fgfr
CY1122478T1 (el) Συνθεσεις που περιεχουν anti-cd38 αντισωματα και λεναλιδομιδη
CY1122159T1 (el) Συνθεσεις irna του γονιδιου serpina1 και μεθοδοι χρησης τους
CY1120035T1 (el) Πυριμιδοπυριμιδινονες χρησιμες ως αναστολεις της wee-1 κινασης
EA201891910A1 (ru) Гетероарильные ингибиторы pad4
CY1123490T1 (el) Συνθεσεις που προερχονται απο χιτοζανη
CL2016000326A1 (es) Composiciones y método para tratar condiciones asociadas con el complemento
EA201591137A1 (ru) Ингибиторы mk2 и их применения
TR201811764T4 (tr) Kinaz inhibitörleri olarak aminoheteroaril benzamidleri.
EA201592225A1 (ru) КОМПОЗИЦИИ НА ОСНОВЕ iRNA TMPRSS6 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
MX2015012401A (es) Composiciones y metodos de alterar niveles de colesterol.
EA201891251A1 (ru) Бициклические ингибиторы pad4
CY1117654T1 (el) Πολυαιθυλενογλυκολιωμενη απελινη και χρησεις αυτης
EA201891347A1 (ru) Аза-бензимидазольные ингибиторы pad4
CY1120597T1 (el) Νεα χρηση
EA201591705A1 (ru) Композиции и способы для диагностики и лечения рака печени
CY1122998T1 (el) Μεθοδοι και συνθεσεις για την αντιμετωπιση της καταθλιψης χρησιμοποιωντας κυκλοβενζαπρινη
EA201690557A1 (ru) Способы лечения синдрома ломкой х-хромосомы и связанных расстройств
CY1124378T1 (el) Ενωσεις για αγωγη του αποκλεισμου επαναμυελινωσης σε παθησεις που συσχετιζονται με την εκφραση της πρωτεϊνης φακελου herv-w
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
CY1120276T1 (el) Απομονωμενη στερεη μορφη μονοϋδροχλωρικη αναμορελινης με χαμηλη γραμμομοριακη αναλογια χλωριου:αναμορελινης και χαμηλη περιεκτικοτητασε καταλοιπα οργανικου διαλυτη
EA201591709A1 (ru) 5-бром-индирубины
CY1119470T1 (el) Γαλακταγωγες συνθεσεις με βαση φωσφατιδυλοσερινη
BR112016012248A2 (pt) método de tratamento de nefropatia